SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMYLIN PHARM.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: cal buzzell who wrote (13)10/31/1996 2:24:00 AM
From: Michael Collins   of 52
 
My thinking is that when your stock is up pretty good, that is the time
to do a public offering. If the Phase III results for amylin are not too
good then obviously the stock price would tank and the company
would have to go through some serious shareholder dilution to get
the same amount of funds. No they probably don't need the cash
due to the partnership with J&J but JUST IN CASE if the phase III
results are bad they may no longer have J&J to back them so they
want a decent cash hoard now to insure them for the future. And now
with the stock price at a decent level, they have decided to do it
which is probably a good idea especially if you're investing in Amylin
for the long-term.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News